This is a routine initial ownership disclosure with no trading activity. Monitor for future Form 4 filings to track any open-market purchases or sales by Berendt, which could signal insider conviction.
Price Chart
Executive Summary
Michael J. Berendt filed an initial statement of beneficial ownership (Form 3) with Retension Pharmaceuticals, Inc., disclosing stock options and convertible preferred stock holdings. The filing is a routine Section 16 compliance requirement for a new reporting insider and contains no material financial or operational information.
Key Facts
- Michael J. Berendt filed a Form 3 as a new reporting insider of Retension Pharmaceuticals, Inc. (RTSN).
- Berendt holds stock options to buy 40,258 shares at $1.43 (expiring 2034-09-22) and 24,155 shares at $2.43 (expiring 2035-10-30).
- Berendt holds 4,026 shares of Series A Convertible Preferred Stock and 2,640 shares of Series B Convertible Preferred Stock, each convertible into common stock at a 1:1 ratio.
- The Series A and B Preferred Stock automatically convert into common stock immediately prior to the closing of the company's initial public offering.
Financial Impact
No financial impact — the filing discloses existing holdings and options, not a transaction or change in ownership.
Risk Factors
- No material risks identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001213900-26-108132 |
| Document: 0001213900-26-108132-index-headers.html | 0001213900-26-108132 |
| Document: 0001213900-26-108132-index.html | 0001213900-26-108132 |
| Document: 0001213900-26-108132.txt | 0001213900-26-108132 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $15.25 | awaiting T+5 | — | $15.25 (0.00%) |
Oct 16, 2026 10d ago | SC 13G | $16.33 $14.65 | ▼ −10.29% | ▼ −10.14% | $15.25 (−6.61%) |
Oct 16, 2026 10d ago | SC 13G | $14.07 $15.25 | ▲ +8.39% | ▲ +8.82% | $15.25 (+8.39%) |
Oct 15, 2026 11d ago | SC 13G | $12.21 $15.50 | ▲ +26.95% | ▲ +27.96% | $15.25 (+24.90%) |
Oct 14, 2026 12d ago | SC 13D | $12.21 $15.50 | ▲ +26.95% | ▲ +27.96% | $15.25 (+24.90%) |
Oct 13, 2026 13d ago | Insider Cluster | $11.64 $15.00 | ▲ +28.87% | ▲ +28.41% | $15.25 (+31.01%) |
Oct 13, 2026 13d ago | 3 | $11.64 $15.00 | ▲ +28.87% | ▲ +28.41% | $15.25 (+31.01%) |
Oct 9, 2026 17d ago | 424B4 | $11.32 $16.33 | ▲ +44.26% | ▲ +45.75% | $15.25 (+34.72%) |
Oct 9, 2026 17d ago | EFFECT | $10.53 $14.07 | ▲ +33.62% | ▲ +35.59% | $15.25 (+44.82%) |
Oct 8, 2026 18d ago | 3 | $10.53 $14.07 | ▲ +33.62% | ▲ +35.59% | $15.25 (+44.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers